It's known that aged hematopoietic stem cells retain an intrinsically open chromatin state that resists rejuvenation when placed in a young environment [5]. Yet pharmacological inhibition of RhoA compresses this accessibility and restores function [6], showing that the actin‑RhoA pathway can remodel the epigenome independently of systemic cues. We hypothesize that sustained RhoA activity in aged stem cells locks nucleosomes into a conformation that prevents transient breathing movements required for transcription factor binding at lineage‑specific enhancers, thereby uncoupling chromatin state from circulating rejuvenating signals. In this model, RhoA‑mediated nuclear actin polymerization stabilizes a rigid nucleosome array that occludes distal regulatory elements even when youthful plasma provides activating cues. Consequently, inhibiting RhoA restores nucleosome dynamics, enhances enhancer accessibility, and permits aged stem cells to interpret systemic factors as functional output.

Testable predictions follow from this mechanism. First, measuring nucleosome breathing using assay for transposase‑accessible chromatin coupled with micrococcal nuclease sequencing (ATAC‑MNase) will show reduced short‑fragment peaks at enhancers in aged HSCs compared with young cells, and RhoA inhibition will selectively increase these peaks without altering global ATAC‑seq signal intensity. Second, we can't detect increased breathing‑associated accessibility when aged HSCs are exposed to young serum unless RhoA is concurrently inhibited; the combination will produce a synergistic rise in enhancer openness and downstream target gene expression. Third, lineage‑specific transcription factors such as PU.1 in HSCs or MyoD in satellite cells will exhibit increased residence time on chromatin after RhoA inhibition, detectable by fluorescence recovery after photobleaching (FRAP) of tagged factors, only when cells are also incubated with youthful plasma. Fourth, functional assays will reveal that RhoA inhibition alone improves self‑renewal in vitro, but maximal competitive repopulation capacity in vivo requires both RhoA suppression and exposure to youthful circulation, demonstrating that chromatin compaction acts as a gate rather than a sole driver of aging.

Falsification occurs if either (a) RhoA inhibition does not alter nucleosome breathing metrics at enhancers, (b) young plasma fails to augment accessibility or transcription factor binding even when RhoA is inhibited, or (c) aged stem cells regain full rejuvenative capacity solely through RhoA suppression without any systemic input. Each outcome would challenge the notion that RhoA‑controlled chromatin rigidity serves as the primary barrier preventing aged stem cells from responding to youthful environments, redirecting focus toward alternative epigenetic locks or signaling defects.